The center-right American Action Forum says whether the US Congress elects to permanently repeal the device excise take or let tax collection restart in 2018 will have stark implications for medtech jobs.
If Congress repeals the 2.3% excise tax on device sales before the levy is scheduled to reactivate in 2018, the medtech industry will be on a path to regain the approximately 28,000 net jobs that data suggests were lost in the sector between 2013 and 2015 by about the year 2021, according to projections by the American Action Forum, a Washington, DC-based think tank.
But if tax collection is allowed to restart, an additional 25,000 jobs could be lost during a similar period, says...
Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.
Multi-cancer diagnostics can help get oncology patients the treatment they need more quickly, but lack of reimbursement has kept such tests out of reach for many patients. Bills providing coverage have passed or are under consideration in more than half of the states and have been introduced in both houses of US Congress.
A government report requested by US lawmakers Debbie Dingell and Anna Eshoo to review the FDA’s postmarket surveillance of medical devices stresses that strengthening the system is critical to addressing adverse events linked to devices after they hit the market.
A bipartisan bill now in the US Senate seeks to change the classification of implantable hearing aid devices to allow Medicare to reimburse for the devices, potentially expanding access for many Americans who require them.
This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.
Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.
